BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10773592)

  • 1. Bone mineral density and serum levels of aminoterminal propeptides and cross-linked N-telopeptides of type I collagen in elderly men.
    Chandani AK; Scariano JK; Glew RH; Clemens JD; Garry PJ; Baumgartner RN
    Bone; 2000 May; 26(5):513-8. PubMed ID: 10773592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of cross-linked N-telopeptides and aminoterminal propeptides of type I collagen indicate low bone mineral density in elderly women.
    Scariano JK; Glew RH; Bou-Serhal CE; Clemens JD; Garry PJ; Baumgartner RN
    Bone; 1998 Nov; 23(5):471-7. PubMed ID: 9823455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating cortisone levels are associated with biochemical markers of bone formation and lumbar spine BMD: the Hertfordshire Cohort Study.
    Cooper MS; Syddall HE; Fall CH; Wood PJ; Stewart PM; Cooper C; Dennison EM
    Clin Endocrinol (Oxf); 2005 Jun; 62(6):692-7. PubMed ID: 15943831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early changes in urinary cross-linked N-terminal telopeptides of type I collagen level correlate with 1-year response of lumbar bone mineral density to alendronate in postmenopausal Japanese women with osteoporosis.
    Iwamoto J; Takeda T; Sato Y; Uzawa M
    J Bone Miner Metab; 2005; 23(3):238-42. PubMed ID: 15838627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased urinary N-telopeptide cross-linked type 1 collagen predicts bone loss in patients with inflammatory bowel disease.
    Dresner-Pollak R; Karmeli F; Eliakim R; Ackerman Z; Rachmilewitz D
    Am J Gastroenterol; 2000 Mar; 95(3):699-704. PubMed ID: 10710060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-related changes of serum bone alkaline phosphatase and cross-linked C-telopeptides of type I collagen and the relationship with bone mineral density in Chinese women.
    Shan PF; Wu XP; Zhang H; Luo XH; Cao XZ; Xie H; Liu SP; Pi YZ; Fang TY; Liu H; Chen ZH; Zhong N; Liao EY
    Clin Chim Acta; 2006 Apr; 366(1-2):233-8. PubMed ID: 16330011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential analysis of biochemical markers of bone resorption and bone densitometry in multiple myeloma.
    Abildgaard N; Brixen K; Eriksen EF; Kristensen JE; Nielsen JL; Heickendorff L
    Haematologica; 2004 May; 89(5):567-77. PubMed ID: 15136220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical usefulness of cross-linked N-telopeptide of type I collagen (NTx) as a bone metastatic marker in patients with prostate cancer--comparison with serum PICP, PINP and ICTP].
    Kobayashi Y; Ochi M; Tokue A
    Hinyokika Kiyo; 2000 Dec; 46(12):869-72. PubMed ID: 11211802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic efficacy of serum cross-linked N-telopeptide (NTx) and aminoterminal procollagen extension propeptide (PINP) measurements for identifying elderly women with decreased bone mineral density.
    Scariano JK; Garry PJ; Montoya GD; Duran-Valdez E; Baumgartner RN
    Scand J Clin Lab Invest; 2002; 62(3):237-43. PubMed ID: 12088343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women.
    Papakitsou EF; Margioris AN; Dretakis KE; Trovas G; Zoras U; Lyritis G; Dretakis EK; Stergiopoulos K
    Maturitas; 2004 Mar; 47(3):185-93. PubMed ID: 15036488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of measuring soluble receptor activators of nuclear factor-kappaB ligand and osteoprotegerin in bone metabolism of elderly women.
    Chiba Y; Onouchi T; Ikeda T; Adachi J; Tamura Y; Horiuchi T
    Gerontology; 2009; 55(3):275-80. PubMed ID: 19158438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Age-related and menopause-related changes of urinary excretion of C- and N-terminal cross-linked telopeptides of type I collagen and the relationships thereof with menopause-related bone loss].
    Liu SP; Liao EY; Wu XP; Cao XZ; Shan PF; Su X
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):371-5. PubMed ID: 16677543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationships between circulating matrix metalloproteinase-1, -2 and metalloproteinase-1 levels and bone biochemical markers and bone mineral density in Chinese postmenopausal women].
    Guo LJ; Luo XH; Wu XP; Xie H; Zhou HD; Zhang H; Cao XZ; Liao EY
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(11):734-7. PubMed ID: 15949377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone mineral metabolism in adults with beta-thalassaemia major and intermedia.
    Dresner Pollack R; Rachmilewitz E; Blumenfeld A; Idelson M; Goldfarb AW
    Br J Haematol; 2000 Dec; 111(3):902-7. PubMed ID: 11122154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis.
    Chopin F; Garnero P; le Henanff A; Debiais F; Daragon A; Roux C; Sany J; Wendling D; Zarnitsky C; Ravaud P; Thomas T
    Ann Rheum Dis; 2008 Mar; 67(3):353-7. PubMed ID: 17644538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease.
    Bjøro K; Brandsaeter B; Wiencke K; Bjøro T; Godang K; Bollerslev J; Schrumpf E
    Scand J Gastroenterol; 2003 Mar; 38(3):320-7. PubMed ID: 12737449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of vitamin D and parathyroid hormone in the regulation of bone turnover and bone mass in men: the MINOS study.
    Szulc P; Munoz F; Marchand F; Chapuy MC; Delmas PD
    Calcif Tissue Int; 2003 Dec; 73(6):520-30. PubMed ID: 12958693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type I collagen metabolites as tumor markers in patients with lung carcinoma.
    Kobayashi T; Gabazza EC; Taguchi O; Risteli J; Risteli L; Kobayashi H; Yasui H; Yuda H; Sakai T; Kaneda M; Adachi Y
    Cancer; 1999 May; 85(9):1951-7. PubMed ID: 10223235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of age-related chronic immobility on markers of bone turnover.
    Chen JS; Cameron ID; Cumming RG; Lord SR; March LM; Sambrook PN; Simpson JM; Seibel MJ
    J Bone Miner Res; 2006 Feb; 21(2):324-31. PubMed ID: 16418789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous zoledronic acid 5 mg in the treatment of postmenopausal women with low bone density previously treated with alendronate.
    McClung M; Recker R; Miller P; Fiske D; Minkoff J; Kriegman A; Zhou W; Adera M; Davis J
    Bone; 2007 Jul; 41(1):122-8. PubMed ID: 17468062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.